Table 2

Mean (SD) of age at diagnosis, for all Surveillance, Epidemiology and End Results (SEER) participants, by stage and other clinical characteristics

All patientsStage IAStage IBStage IIAStage IIBStage IIIStage IV
Race—mean (SD)
 Black62.7 (11)61.2 (10)58.9 (11.3)63.8 (10.5)61.8 (10.5)64.5 (11.3)63.4 (11.4)
 Other65.6 (12)60.3 (11.5)65.1 (11.4)64.8 (11.7)65.7 (11.6)67.4 (12.1)66 (12.7)
 White66.4 (11.2)65.5 (11)65.7 (11.9)67.7 (10.4)66.1 (10.8)66.2 (11.5)66.6 (12)
Sex—mean (SD)
 Female66.8 (11.5)64.7 (11.7)63.9 (12.7)67.4 (10.7)66.7 (10.9)67.1 (11.9)67.3 (12.3)
 Male65.2 (11)64.8 (10.5)65.9 (11)66.8 (10.6)64.7 (10.8)65.1 (11)65.1 (11.6)
Location—mean (SD)
 Body66.2 (11.5)63.6 (11.1)65.4 (12.4)67.8 (10)65.2 (11.5)66.2 (11.5)66.7 (11.6)
 Head66 (11.1)65.2 (11.2)65.5 (11.1)67.1 (10.4)65.7 (10.8)66 (11.4)66.2 (11.9)
 Tail65.5 (12.2)64.3 (10.9)63.1 (13.4)66.8 (11.9)65.8 (11.2)67.1 (12.8)65.5 (12.5)
Grade—mean (SD)
 G163.9 (12.4)62.5 (11.3)61.7 (12.8)65.9 (11.4)63.7 (12.1)66 (11.6)63.5 (13.7)
 G266.3 (10.9)66.9 (10.3)65.3 (11.7)67.3 (10.3)65.9 (10.6)66.1 (11.4)66.6 (11.7)
 G366.4 (11.2)66.2 (11.4)67.7 (10.7)67.4 (10.6)66 (10.8)66.1 (11.6)66.4 (11.7)
 G465.3 (11.5)55.6 (9.9)64.9 (10.6)66.3 (12.5)64.5 (11)66.3 (11.8)65.8 (11.5)
Size (cm)—mean (SD)
 <265.6 (11.2)64.8 (11.1) (NA)66.8 (11.1)65 (11)66.4 (11.6)67.3 (11.8)
 2–466.2 (11.1) (NA)65.4 (11.2)67.5 (10.2)66 (10.9)66.1 (11.3)66.1 (12)
 >465.7 (11.6) (NA)63.4 (13.4)66.3 (11.2)65.3 (10.7)66 (11.8)65.9 (12)
T Stage—mean (SD)
 T165.1 (11.4)64.8 (11.1) (NA) (NA)64.3 (11.8) (NA)67.5 (11.7)
 T265.9 (11.9) (NA)64.9 (12) (NA)64.9 (11.4) (NA)67.1 (12.1)
 T366.1 (11) (NA) (NA)67.1 (10.6)65.8 (10.8) (NA)65.6 (12.2)
 T465.9 (11.5) (NA) (NA) (NA) (NA)66.1 (11.5)65.6 (11.6)
N Stage—mean (SD)
 N066.6 (11.4)64.8 (11.1)64.9 (12)67.1 (10.6) (NA)66.8 (11.7)67.3 (11.8)
 N165.4 (11.2) (NA) (NA) (NA)65.7 (10.9)65.1 (11.3)64.7 (12.1)